GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 181 filers reported holding GW PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,625,000 | +295.4% | 7,491 | +77.3% | 0.01% | +66.7% |
| Q3 2020 | $411,000 | -57.1% | 4,225 | -45.9% | 0.01% | -60.0% |
| Q2 2020 | $958,000 | +38.4% | 7,805 | -1.2% | 0.02% | -16.7% |
| Q1 2020 | $692,000 | +7.6% | 7,902 | +28.5% | 0.02% | +350.0% |
| Q4 2019 | $643,000 | -81.9% | 6,148 | -80.1% | 0.00% | -87.5% |
| Q3 2019 | $3,552,000 | -47.2% | 30,876 | -20.9% | 0.03% | -51.5% |
| Q2 2019 | $6,726,000 | +962.6% | 39,016 | +939.6% | 0.07% | +842.9% |
| Q1 2019 | $633,000 | -22.9% | 3,753 | -55.5% | 0.01% | -30.0% |
| Q4 2018 | $821,000 | +9.8% | 8,435 | +94.7% | 0.01% | +11.1% |
| Q3 2018 | $748,000 | +256.2% | 4,332 | +109.5% | 0.01% | +125.0% |
| Q3 2017 | $210,000 | – | 2,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $21,655,000 | 13.09% |
| Lamond Capital Partners LLC | 120,000 | $10,964,000 | 5.47% |
| GREAT POINT PARTNERS LLC | 100,000 | $6,944,000 | 2.91% |
| Perceptive Advisors | 400,000 | $27,776,000 | 2.06% |
| Iguana Healthcare Management, LLC | 60,687 | $4,214,000 | 1.39% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 46,000 | $3,195,000 | 0.92% |
| FT Options LLC | 51,300 | $1,191,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 310,122 | $21,535,000 | 0.87% |
| Folger Hill Asset Management LP | 176,033 | $12,224,000 | 0.74% |
| CLOUGH CAPITAL PARTNERS L P | 220,276 | $15,296,000 | 0.72% |